Andrew Hedin

Andrew Hedin

Director/Board Member at
Nido Biosciences, Inc.
41 year
Health Technology
Finance
Consumer Services

Profile

Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.

Andrew Hedin active positions

CompaniesPositionStart
Private Equity Investor 01/07/2015
Director/Board Member -

Former positions of Andrew Hedin

CompaniesPositionEnd
KYMERA THERAPEUTICS, INC. Director/Board Member 16/06/2021
Private Equity Analyst 30/07/2013
TSCAN THERAPEUTICS, INC. Director/Board Member -
Corporate Officer/Principal -
See the detail of Andrew Hedin's experience

Training of Andrew Hedin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!